Elevance Health's third-quarter shareholders' net income rose 14.8% to $1.37B, while nine-month shareholders' net income fell 10.2% to $4.59B, including a loss contingency accrual for Medicare Advantage risk adjustment data resubmission.

Filed October 21, 2026 · Period ending September 30, 2026 · Compared to 10-Q Oct 21, 2025 · ~1 min read

Key Changes

• high

  Operating cash flow for the nine months increased 78.6% to $7.51B, primarily due to favorable working capital impacts, partially offset by lower shareholders' net income.

  view on EDGAR →
• medium

  Total medical membership declined 1.1% to 44.9 million medical members, with the decrease primarily driven by attrition in Medicaid membership, primarily as a result of eligibility redeterminations, and decreases in our Medicare Advantage, Commercial Risk-Based and FEP® businesses.

  view on EDGAR →
• low

  The effective tax rate for the quarter rose to 25.1% from 15.6%, primarily due to investment tax credits purchased and recognized in the prior-year quarter, with less tax credits purchased in the current-year quarter.

  view on EDGAR →